Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quick Listen: Scrip’s Five Must-Know Things

Executive Summary

Join us for a brief audio tour around the past week's major biopharma industry developments, as reported by Scrip's global team.

This episode includes the big stories around the world for the business week ended 4 December 2020.

On the plate this time are further rapid-fire developments with COVID-19 vaccines, a new corporate alliance for brain disorders, partnering strategy in infectious diseases, and a look at some of the winners of this year’s Scrip Awards.

 

Stories mentioned in this episode:

(Also see "UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine" - Scrip, 2 Dec, 2020.)

(Also see "Moderna Files COVID-19 Vaccine After Second Impressive Read-Out" - Scrip, 30 Nov, 2020.)

(Also see "Biogen And Sage On Plans To Build A Brain Franchise Together" - Scrip, 30 Nov, 2020.)

(Also see "Roche’s COVID-19 Collaboration Strategy Sees Promise In Combinations" - Scrip, 27 Nov, 2020.)

(Also see "Digital Scrip Awards Celebrate Biopharma After An Exceptional Year" - Scrip, 2 Dec, 2020.)

These and all Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts, TuneIn and Google Play and also via smart speakers - just make sure one of these providers is set up as your default for podcasts, and then ask for "Pharma Intelligence podcasts".

Related Content

Topics

UsernamePublicRestriction

Register

SC143435

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel